Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 25, 2015 3:30 AM ET


Company Overview of Tokai Pharmaceuticals, Inc.

Key Executives for Tokai Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Jodie Pope Morrison 12 RelationshipsChief Executive Officer, President and Director39
Lee H. Kalowski No RelationshipsChief Financial Officer33
Karen J. Ferrante M.D.18 RelationshipsChief Medical Officer and Head of Research & Development56
Philip W. Kantoff M.D.76 RelationshipsChief Clinical Research Officer and Member of Medical Advisory Committee--
Jessica Fees CPANo RelationshipsVice President of Finance--

Tokai Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Seth L. Harrison M.D. 41 RelationshipsApple Tree Partners53
Jodie Pope Morrison 12 RelationshipsTokai Pharmaceuticals, Inc.39
Philip W. Kantoff M.D. 76 RelationshipsTokai Pharmaceuticals, Inc.--
Timothy Joseph Barberich 78 RelationshipsGI Dynamics, Inc.66
Stephen Buckley Jr. 26 RelationshipsEnanta Pharmaceuticals, Inc.63
View All Board Members

Tokai Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jr.Stephen Buckley26 Relationships4 Executives
Compensation Committee Timothy Joseph Barberich78 Relationships2 Executives
Nominating Committee M.D.Seth L. Harrison41 Relationships2 Executives
Corporate Governance Committee M.D.Seth L. Harrison41 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$422.0K
Compensation as of Fiscal Year 2013
Tokai Pharmaceuticals, Inc. CEO Compensation
Industry Average


Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET
David Charne Joins Aunt Fannie's Board of Directors
April 14, 2015 1:38 PM ET
EMS Find, Inc. Announces Executive Changes
April 07, 2015 5:26 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tokai Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at